MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 821 to 840 of 166,322 approvalsPage 42 of 8317

Indobufen Tablets

Approval Number: 国药准字H20253852
Registration: Apr 8, 2025

Alendronate Sodium Tablets

Approval Number: 国药准字H20253811
Registration: Apr 8, 2025

Sodium Bicarbonate Ringer's Injection

Approval Number: 国药准字H20258059
Registration: Apr 8, 2025

Zoledronic Acid Injection

Approval Number: 国药准字H20253810
Registration: Apr 8, 2025

Mercaptopurine Tablets

Approval Number: 国药准字H20253809
Registration: Apr 8, 2025

Oseltamivir Phosphate for Suspension

Approval Number: 国药准字H20253829
Registration: Apr 8, 2025

Dexamethasone Sodium Phosphate Injection

Approval Number: 国药准字H20253844
Registration: Apr 8, 2025

Ceftobiprole Medocaril Sodium for Injection

Approval Number: 国药准字H20253861
Registration: Apr 8, 2025

Indapamide Sustained Release Tablets

Approval Number: 国药准字H20253856
Registration: Apr 8, 2025

Montmorillonite Suspension

Approval Number: 国药准字H20253808
Registration: Apr 8, 2025

Haloperidol Injection

Approval Number: 国药准字H20253845
Registration: Apr 8, 2025

Oxygen

Approval Number: 国药准字H20253860
Registration: Apr 8, 2025

Oseltamivir Phosphate for Suspension

Approval Number: 国药准字H20253827
Registration: Apr 8, 2025

Oxacillin Sodium for Injection

Approval Number: 国药准字H20253834
Registration: Apr 8, 2025

Levofloxacin Eye Drops

Approval Number: 国药准字H20253857
Registration: Apr 8, 2025

Oseltamivir Phosphate for Suspension

Approval Number: 国药准字H20253826
Registration: Apr 8, 2025

Roxadustat Capsules

Approval Number: 国药准字H20253815
Registration: Apr 8, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.